Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The TIE2 receptor tyrosine kinase, also known as TEK or CD202B, is a cell surface protein primarily expressed in endothelial cells. It plays a critical role in blood vessel formation (vasculogenesis and angiogenesis), maintenance, and vascular homeostasis. Ligand binding induces receptor dimerization or higher-order clustering, which is necessary for efficient signal transduction, autophosphorylation on specific tyrosine residues within its intracellular domain, and initiation of downstream signaling pathways that regulate endothelial cell behavior. Mutations in *TEK* are linked to inherited venous malformations, and TIE2 expression is associated with tumor angiogenesis.
Tyrosine kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TIE2 Receptor Tyrosine Kinase (TIE2).